BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18677780)

  • 1. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status.
    Mathew JL; El Dib R; Mathew PJ; Boxall EH; Brok J
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006481. PubMed ID: 18677780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A immunisation in persons not previously exposed to hepatitis A.
    Irving GJ; Holden J; Yang R; Pope D
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD009051. PubMed ID: 22786522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers.
    Lee C; Gong Y; Brok J; Boxall EH; Gluud C
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004790. PubMed ID: 16625613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Booster dose vaccination for preventing hepatitis B.
    Poorolajal J; Hooshmand E
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008256. PubMed ID: 27271960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Booster dose vaccination for preventing hepatitis B.
    Poorolajal J; Mahmoodi M; Haghdoost A; Majdzadeh R; Nasseri-Moghaddam S; Ghalichi L; Fotouhi A
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008256. PubMed ID: 21069704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllanthus species for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008960. PubMed ID: 21491412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for preventing hepatitis B in health-care workers.
    Chen W; Gluud C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD000100. PubMed ID: 16235273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination for patients with chronic renal failure.
    Schroth RJ; Hitchon CA; Uhanova J; Noreddin A; Taback SP; Moffatt ME; Zacharias JM
    Cochrane Database Syst Rev; 2004; 2004(3):CD003775. PubMed ID: 15266500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins for preventing hepatitis A.
    Liu JP; Nikolova D; Fei Y
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004181. PubMed ID: 19370595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
    Katz LH; Tur-Kaspa R; Guy DG; Paul M
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006005. PubMed ID: 20614442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.
    Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008516. PubMed ID: 22972122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D supplementation for prevention of cancer in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007469. PubMed ID: 24953955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Ma SS; Saxton JD; Martzen MR; Vandvik PO; Thorlund K; Guyatt GH; Johnston BC
    Cochrane Database Syst Rev; 2013 May; (5):CD006095. PubMed ID: 23728658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003620. PubMed ID: 15846671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.